Daniel Tardiff

CIK: 0002089301

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAMP

Camp4 Therapeutics Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CAMP
Camp4 Therapeutics Corp
Aug 19, 2026
Sale(S)
Direct
1.7K shares at avg. $4.76$8K
CAMP
Camp4 Therapeutics Corp
Apr 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
170K shares-
CAMP
Camp4 Therapeutics Corp
Dec 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
145.5K shares-

		Type	Shares	Price		Ownership
Aug 19, 2026	CAMP Camp4 Therapeutics Corp	Sale(S)	1,738	$4.76	$8,273	Direct
Apr 1, 2026	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	170,000	-	-	Direct
Dec 11, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	145,500	-	-	Direct

1-3 of 3 transactions

About Tardiff Daniel

Tardiff Daniel (SEC CIK 0002089301) files insider reports with the SEC as Chief Scientific Officer of Camp4 Therapeutics Corp (CAMP).

Signal8 holds 4 ownership filings by Tardiff Daniel (1 Form 3, 3 Form 4), filed between Oct 10, 2025 and Aug 19, 2026. Those filings report 3 transactions, from Dec 11, 2025 to Aug 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tardiff Daniel's filings is in WATERTOWN, MA.

Recent filings by Tardiff Daniel

Aug 19, 2026: Open-market sale of CAMP shares (Form 4, code S).
Apr 1, 2026: Grant or award of CAMP derivative securities (Form 4, code A).
Dec 11, 2025: Grant or award of CAMP derivative securities (Form 4, code A).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
5AM Partners VI, LLC, 10% Owner
Young Richard A, Director
Maricich Yuri, Chief Medical Officer
Mandel-Brehm Josh, Chief Executive Officer

How to read Form 4 transaction codes